NFE2L2 and cancer: Recently, there is growing interest in promising Nrf2 activators because many physiological studies showed the Nrf2 activation alleviated pathological conditions, including chronic kidney disease, pulmonary hypertension, neurodegenerative disorder, and cancer [14,15].